/VRCI

VRCI Stock - Verde Science, Inc.

Q: What is the analyst price target for VRCI?

Analyst price target information is not currently available for VRCI.

Q: What is VRCI's market cap?

Market capitalization information is not currently available for VRCI.

Healthcare|Biotechnology|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for VRCI

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2010

FY2011

FY2012

FY2013

FY2014

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-6.16

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2014	FY2013	FY2012	FY2011	FY2010
Revenue	N/A	N/A	$227,660	$151,224	$177,409
Gross Profit	N/A	N/A	$-7,056	$-116,514	$-111,300
Gross Margin	N/A	N/A	-3.1%	-77.0%	-62.7%
Operating Income	$-1,895,888	$-924,207	$-2,030,238	$-219,168	$-375,883
Net Income	$-2,612,479	$-798,141	$-2,117,484	$-71,168	$-597,214
Net Margin	N/A	N/A	-930.1%	-47.1%	-336.6%
EPS	$-6.12	$-2.22	$-14.43	$-24.99	$-274.20

Company Overview

Verde Science, Inc., a pharmaceutical research and development company, focuses on developing a portfolio of cannabinoid based prescription medicines for various medical conditions. The company was formerly known as Rango Energy, Inc. and changed its name to Verde Science, Inc. in May 2014. Verde Science, Inc. was founded in 2007 and is based in Dallas, Texas.

Visit Website